ARNI
Medical abbreviation · Drug Class
| Stands for | Angiotensin receptor-neprilysin inhibitor |
|---|---|
| Categories | Medical |
ARNI stands for Angiotensin receptor-neprilysin inhibitor, a drug class abbreviation.
Heart failure drug class combining an ARB with a neprilysin inhibitor; the only member is sacubitril/valsartan (Entresto). Blocking neprilysin raises natriuretic peptides that promote sodium excretion and relax blood vessels.
Example: Stop lisinopril, wait 36 hours, then start ARNI 24/26 mg BID.
Usage notes
The PARADIGM-HF trial (2014) found sacubitril/valsartan reduced cardiovascular death or heart failure hospitalization by about 20 percent compared with enalapril, leading to FDA approval in 2015. A 36-hour gap is required after stopping an ACE inhibitor because combining them sharply increases angioedema risk.
Related abbreviations
More drug class abbreviations
- ADC – Antibody-drug conjugate
- AED – Antiepileptic drug
- AG – Aminoglycoside
- AGI – Alpha-glucosidase inhibitor
- AI – Aromatase inhibitor
- ARB – Angiotensin II receptor blocker
- ASM – Antiseizure medication
- ASO – Antisense oligonucleotide
- ATD – Antithyroid drug
- BAS – Bile acid sequestrant
- BB – Beta-blocker
- BiTE – Bispecific T-cell engager
See all 113 drug class abbreviations →
This entry is for general education and is not medical advice. Abbreviation use varies between institutions; always confirm in context.